GS-441524 for FIP in Cats: How It Works & India Access

The lab report arrives on your phone at 11 p.m. Your vet has circled three letters: FIP. You open a browser tab, then another, and within minutes you are reading about a molecule called GS-441524. You are not alone. Every month, thousands of cat parents in India search for this exact compound, often within hours of a Feline Infectious Peritonitis (FIP) diagnosis.

GS-441524 for FIP in Cats

This is the page that answers what you are actually trying to find out: what GS-441524 is, how it works inside your cat, what the 84-day protocol looks like week by week, and how to access it in India through BasmiFIP.

What Is GS-441524?

GS-441524 is a nucleoside analogue, a small molecule that looks chemically similar to the building blocks a virus uses to copy itself. It is the parent compound of remdesivir and was identified as the most promising antiviral against feline coronavirus by Dr. Niels Pedersen of UC Davis, whose 2019 clinical trial reported a 92% success rate in cats with FIP.

Before that trial, FIP was considered fatal in nearly every diagnosed cat. After it, the disease became treatable. More than 100,000 cats worldwide have since recovered using GS-441524-based protocols.

The BasmiFIP GS-441524 injectable is supplied at 40 mg/ml, 99.4% purity, in an 8 ml vial. It is the primary antiviral in our FIP product line, and the molecule the rest of this article is about.

How GS-441524 Works Inside a Cat with FIP

FIP is caused by a mutated form of feline coronavirus that infects macrophages, the immune cells meant to defend the body. Once inside those cells, the virus replicates aggressively, triggering the inflammation, effusions, and organ damage that define the disease.

GS-441524 works by inserting itself into the viral RNA chain during replication. Once incorporated, it acts as a chain terminator: the virus cannot finish copying its genome, and replication halts. Because the molecule targets a viral enzyme (RNA-dependent RNA polymerase) rather than a feline one, healthy cells are largely spared.

In plain language: GS-441524 stops the virus from making more of itself, giving your cat's immune system the window it needs to clear the infection and repair tissue.

The Four Forms of FIP and Why the Form Matters

FIP presents in four distinct forms, and the form your cat is diagnosed with determines dosing and route.

1. Wet (effusive) FIP: fluid accumulation in the abdomen or chest. GS-441524 dose: 6 mg/kg daily.

2. Dry (non-effusive) FIP: granulomas in organs without significant fluid. Dose: 8 mg/kg daily.

3. Ocular FIP: uveitis, colour change in the iris, vision changes. Dose: 10 mg/kg daily.

4. Neurological FIP: ataxia, seizures, hind-limb weakness. Dose: 10 mg/kg daily.

Ocular and neurological FIP are two separate forms, not a single category. They require higher doses because GS-441524 must cross the blood-eye and blood-brain barriers to reach the virus.

The 84-Day Protocol: What to Expect Week by Week

The standard FIP protocol is 84 days, or 12 weeks, of daily treatment. This length is not arbitrary. Shorter courses are associated with relapse, and the 84-day mark is what UC Davis and subsequent field data converged on as the duration needed for durable remission.

Week 1: The Turnaround

All FIP cats show visible signs of improvement after 7 days of GS-441524 treatment. Fever typically breaks within 24 to 72 hours. Appetite returns. Effusions begin to reduce. If there is no improvement at all after 7 days, your cat likely does not have FIP, and the diagnosis should be revisited.

Weeks 2 to 4: Stabilisation

Weight starts climbing. Energy returns in noticeable steps. Blood work usually shows globulins beginning to fall and the albumin-to-globulin (A:G) ratio beginning to rise. This is the phase where many cat parents report their cat "feels like themselves again."

Weeks 5 to 8: The Quiet Middle

This is often the hardest stretch emotionally. Your cat looks healthy. The daily injections feel repetitive. The temptation to stop is real. Do not stop. Residual virus is still being suppressed, and stopping early is the single most common cause of relapse.

For stable wet or dry FIP cases without ocular or neurological signs, this is also the window where your vet may transition the cat from injections to the BasmiFIP Dual Antiviral oral capsule (GS-441524 plus EIDD-1931), typically after about 30 days of injections.

Weeks 9 to 12: Finishing Strong

Blood work is rechecked. A:G ratio, total protein, haematocrit, and SAA should be moving into normal ranges. Treatment continues at full dose until day 84.

The 84-Day Observation Period

After the last dose, your cat enters an 84-day observation window. If blood work remains stable and no symptoms return, the cat is considered in remission. Real-world relapse rates with adequate dosing are around 6.5%.

Dual Antiviral Therapy: When GS-441524 Pairs with EIDD-1931

For slower responders or drug-resistant cases, dual-mechanism therapy has become the new standard. Dr. Niels Pedersen of UC Davis confirmed GS-441524 resistance in some cats in 2021, which drove the search for a second antiviral with a different mechanism.

EIDD-1931 is that second antiviral. It is roughly 7.3 times more potent than GS-441524 on a molar basis and works by inducing fatal mutations in the viral genome (lethal mutagenesis) rather than chain termination. The two drugs hit the virus from two angles at once.

A field evaluation of 46 cats by Li and Cheah (2025) showed combined oral GS-441524 and EIDD-1931 achieved 78.3% remission in cases that included slow responders and previously treated cats.

BasmiFIP offers this combination as a single Dual Antiviral oral capsule, taken once daily. Per weight:

• Under 2.5 kg: GS-441524 25 mg + EIDD-1931 5 mg

• 2.5 to 5 kg: GS-441524 35 mg + EIDD-1931 8 mg

• Over 5 kg: GS-441524 50 mg + EIDD-1931 10 mg

Important safety notes: the dual capsule is intended for use after about 30 days of injections or once the cat is stable. It is not used during active ocular or neurological symptoms, during vomiting or diarrhoea, or for cats under 1 year with wet FIP. EIDD-1931-containing products must never be used in pregnant, nursing, or breeding cats due to teratogenic risk.

Drug Interactions to Avoid During GS-441524 Treatment

During the 84-day protocol, avoid:

• Fluoroquinolone antibiotics (enrofloxacin, marbofloxacin)

• Spot-on flea medications

• Lysine supplements

• Immune boosters or interferons

These can interfere with antiviral activity or worsen the inflammatory picture. Your BasmiFIP consultation team will review your cat's current medications before treatment begins.

Supporting the Liver and Kidneys During Treatment

GS-441524 itself has a strong safety profile, but FIP is a systemic inflammatory disease, and the liver and kidneys often take a hit before treatment even starts. As adjunct support, your vet may recommend:

• LiverRx (SAMe 90 mg, Silybin A+B 9 mg, Vitamin E, Vitamin C): for hepatic support during recovery.

• KidneyRx (Omega-3, L-Carnitine, Chitosan, Cranberry extract, and renal-supportive minerals): for kidney support, especially in cats with elevated SDMA or creatinine.

These are nutraceuticals, not antivirals. They do not treat FIP. They support the organs while GS-441524 does the antiviral work.

Where to Get GS-441524 in India

BasmiFIP delivers GS-441524 across India, including Bengaluru, Mumbai, Delhi, Pune, Hyderabad, Chennai, Kolkata, Ahmedabad, Jaipur, and pan-India tier-2 and tier-3 cities. Every order includes:

• BasmiFIP GS-441524 injectable (40 mg/ml, 99.4% purity, 8 ml vial), or the Dual Antiviral oral capsule once your cat is stable

• Free expert consultation with our FIP-experienced team

• Dosing calculation based on your cat's weight, FIP form, and current blood work

• Week-by-week monitoring guidance

• Cold-chain handling where required

If you are searching "GS-441524 buy online" from India, this is the page that resolves it. Place an enquiry through basmifipindia.com and our team will respond with a treatment plan, pricing, and next-day shipping options.

A Note on What GS-441524 Is Not

GS-441524 is not a guarantee. It is the best-evidenced antiviral available for FIP today, with a 92% success rate in the original UC Davis trial and over 100,000 cats recovered worldwide since 2019. It is the difference between a diagnosis that used to end one way, and a diagnosis that now ends, for most cats, in remission.

That is what we mean when we say BasmiFIP gives cats a second chance.

FAQ

Is GS-441524 the same as remdesivir?

No. GS-441524 is the parent nucleoside of remdesivir. Remdesivir is a prodrug that the body converts back into GS-441524. For FIP, GS-441524 is the active molecule and is delivered directly rather than through a prodrug step.

How soon will I know if GS-441524 is working?

Most cats show clinical improvement, including reduced fever and returning appetite, within 24 to 72 hours. By day 7, improvement should be unmistakable. If you see no change after 7 days, contact your vet and reconsider the diagnosis.

Can I switch from injections to oral capsules partway through treatment?

Yes, in many cases. For stable wet or dry FIP without ocular or neurological involvement, a transition to the BasmiFIP Dual Antiviral oral capsule is typically considered after about 30 days of injections. Cats with active ocular or neurological symptoms should remain on injections at 10 mg/kg.

Is GS-441524 safe for kittens and senior cats?

GS-441524 has been used safely across a wide age range, from young kittens to senior cats. Dosing is weight-based and adjusted as the cat gains weight during treatment. Our consultation team helps you reweigh and recalculate weekly.

How do I order GS-441524 from BasmiFIP in India?

Visit basmifipindia.com and submit an enquiry with your cat's diagnosis, weight, and recent blood work. Our team will respond with a tailored protocol, the appropriate BasmiFIP GS-441524 product, and shipping details for your city. Free expert consultation is included with every order.